[HTML][HTML] Clinical characteristics, outcomes, and genetic findings of patients with catecholaminergic polymorphic ventricular tachycardia in Hong Kong: A systematic …

JMH Hui, YHA Lee, K Hui, J Zhou, DI Satti… - Annals of Clinical …, 2022 - journals.lww.com
Catecholaminergic polymorphic ventricular tachycardia (CPVT) is a rare cardiac ion
channelopathy. This was the first systematic review of published works on the clinical …

Clinical characteristics, genetic findings and arrhythmic outcomes of patients with catecholaminergic polymorphic ventricular tachycardia from China: A systematic …

J Leung, S Lee, J Zhou, K Jeevaratnam, I Lakhani… - Life, 2022 - mdpi.com
Introduction: Catecholaminergic polymorphic ventricular tachycardia (CPVT) is a rare
inherited cardiac ion channelopathy. The present study aims to examine the clinical …

104 Analysis of clinical characteristics, genetic basis, management and arrhythmic outcomes of patients with catecholaminergic polymorphic ventricular tachycardia …

G Tse, S Lee, KB Waleed, JMH Hui, I Lakhani - 2022 - heart.bmj.com
Introduction Catecholaminergic polymorphic ventricular tachycardia (CPVT) is a rare cardiac
ion channelopathy. The aim of this study is to examine the clinical characteristics, genetic …

Arrhythmic outcomes in catecholaminergic polymorphic ventricular tachycardia

S Lee, J Zhou, K Jeevaratnam, I Lakhani, WT Wong… - medRxiv, 2021 - medrxiv.org
Introduction Catecholaminergic polymorphic ventricular tachycardia (CPVT) is a rare cardiac
ion channelopathy. The aim of this study is to examine the genetic basis and identify pre …

Clinical and genetic profiles of chinese pediatric patients with catecholaminergic polymorphic ventricular tachycardia

Y Yan, L Tang, X Wang, K Zhou, F Hu, H Duan… - Orphanet Journal of …, 2023 - Springer
Backgrounds Catecholaminergic polymorphic ventricular tachycardia (CPVT) is a rare but
lethal cardiac ion channelopathy. Delayed diagnosis and misdiagnosis remain a matter of …

[HTML][HTML] Genetic and clinical characteristics of catecholaminergic polymorphic ventricular tachycardia in a Taiwanese nationwide cohort

GCY Hsu, MH Wu, JY Chuang, SN Chiu, MT Lin… - Journal of the Formosan …, 2024 - Elsevier
Background Catecholaminergic polymorphic ventricular tachycardia (CPVT) is a rare and
lethal arrhythmia. Ryanodine receptor 2 (RYR2) mutation accounts for∼ 60% of CPVT …

Clinical characteristics, genetic basis and healthcare resource utilisation and costs in patients with catecholaminergic polymorphic ventricular tachycardia: a …

CT Chung, S Lee, J Zhou, OHI Chou… - Reviews in …, 2022 - scholars.cityu.edu.hk
Background: This study examined the clinical characteristics, genetic basis, healthcare
utilisation and costs of catecholaminergic ventricular tachycardia (CPVT) patients from a …

Long-term follow-up of patients with catecholaminergic polymorphic ventricular arrhythmia

M Veith, I El-Battrawy, G Roterberg… - Journal of Clinical …, 2020 - mdpi.com
Background: Catecholaminergic polymorphic ventricular tachycardia (CPVT) is a rare
inherited disorder causing life-threatening arrhythmias. Long-term outcome studies of the …

Catecholaminergic polymorphic ventricular tachycardia: genetics, natural history and response to therapy

T Rossenbacker, R Bloise, L De Giuli… - 2007 - Am Heart Assoc
Background: Catecholaminergic polymorphic ventricular tachycardia (CPVT) is an
arrhythmo-genic cardiac disease predisposing affected individuals to sudden cardiac death …

[HTML][HTML] Catecholaminergic polymorphic ventricular tachycardia

M Abbas, C Miles, E Behr - Arrhythmia & Electrophysiology Review, 2022 - ncbi.nlm.nih.gov
Catecholaminergic polymorphic ventricular tachycardia (CPVT) is an inherited arrhythmia
syndrome characterised by adenergically mediated bidirectional and/or polymorphic …